NCT03150641 is a NA clinical trial of Umbilical cord clamping in Maternal Blood Loss, sponsored by Columbia University.

Who is sponsoring NCT03150641?

NCT03150641 is sponsored by Columbia University.

What drugs are being tested in NCT03150641?

Interventions in NCT03150641: Umbilical cord clamping.

What condition does NCT03150641 study?

NCT03150641 studies Maternal Blood Loss, Cesarean Delivery, Delayed Cord Clamping, Neonatal Health.

Is NCT03150641 still recruiting?

NCT03150641 is currently completed. Last updated 22 May 2019.

Last reviewed 2019-05-22 · How we verify

NCT03150641

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Delayed Cord Clamping at Term Cesarean

Completed NA Last updated 22 May 2019

What this trial tests

NA trial testing Umbilical cord clamping in Maternal Blood Loss in 113 participants. Completed in 31 March 2018.

Timeline

18 September 2017

Primary endpoint
30 March 2018

31 March 2018

Quick facts

Lead sponsor	Columbia University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	prevention
Enrollment	113
Start date	18 September 2017
Primary completion	30 March 2018
Estimated completion	31 March 2018
Sites	1 location across United States

Drugs / interventions tested

Umbilical cord clamping

Conditions studied

Maternal Blood Loss — all drugs for Maternal Blood Loss →
Cesarean Delivery — all drugs for Cesarean Delivery →
Delayed Cord Clamping — all drugs for Delayed Cord Clamping →
Neonatal Health — all drugs for Neonatal Health →

Sponsor

Columbia University

Who can join

Adults 18 to 60, female only, with Maternal Blood Loss or Cesarean Delivery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this research study is to find out how delaying cutting the umbilical cord until one minute after delivery of the baby during a cesarean impacts the amount of blood the mother loses during surgery. The study will also examine the benefits to the newborn from delayed cord clamping during cesarean.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Effect of Delayed vs Immediate Umbilical Cord Clamping on Maternal Blood Loss in Term Cesarean Delivery: A Randomized Clinical Trial.
Purisch SE, Ananth CV, Arditi B, Mauney L, et al · · 2019 · cited 48× · PMID 31742629 · DOI 10.1001/jama.2019.15995

Verify or expand the search:

Other Columbia University trials

Trials by the same sponsor.

NCT06558422 — Human Models of Selective Insulin Resistance: Pancreatic Clamp · Phase 1 · not yet recruiting
NCT07264582 — HIV/STI/HCV Testing and Overdose Prevention Among Survivors of Sex Trafficking · NA · not yet recruiting
NCT05992415 — Know Your Pressures NYC · NA · not yet recruiting
NCT05645211 — The AgRP and GH/IGF-1 Axis in Children · not yet recruiting
NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03150641 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Columbia University
Last refreshed: 22 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03150641.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing